课题基金 / 基金详情

Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma

Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
优化皮肤 T 细胞淋巴瘤高通量 TCR 测序的分析前样品处理
批准号:
10814026
负责人:
Rachael Ann Clark
金额:
$4.38万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-05-31

项目摘要

项目成果

Rachael Ann Clark的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT AND SPECIFIC AIMS Formalin fixation is a common method used to preserve skin biopsies in both clinical practice and clinical trials. Formalin-fixed, paraffin-embedded (FFPE) tissues have excellent tissue morphology, but DNA and RNA are degraded by formalin fixation 1 . High throughput sequencing of the rearranged T cell receptor genes (HTS) has transformed the diagnosis, care and assessment of therapeutic responses in patients with cutaneous T cell lymphoma (CTCL)2-5. HTS results are highly reproducible in frozen CTCL skin biopsies but the formalin used to preserve skin biopsies in many clinical trials degrades DNA and affects HTS measurements, potentially causing errors in patient diagnosis, assessment of responses and choices of therapy. The overarching goal of the funded parent U01 grant is to identify a single uniform optimal tissue processing approach for small skin biopsies to study CTCL that will give accurate and reproducible DNA, RNA and protein measurements, maintain excellent histology, and preserve remaining tissue for future measurement of emerging biomarkers. Hypothesis: Non-cross-linking tissue fixatives will maintain nucleic acid and protein integrity without sacrificing histopathologic quality and quantitative corrections for DNA degradation in banked formalin-fixed specimens will allow accurate HTS measurements in existing skin biopsies from patients with CTCL.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
同种异体造血干细胞移植后复发性皮肤 T 细胞淋巴瘤的治疗:回顾代表性患者病例。
DOI: 10.1111/dth.15538
发表时间: 2022
期刊: Dermatologic therapy
影响因子: 3.6
作者: [Weiner,DavidM, Lewis,DanielJ, Spaccarelli,NatalieG, Clark,RachaelA, Nasta,SunitaD, Loren,AlisonW, Rook,AlainH, Kim,EllenJ]
通讯作者: Kim,EllenJ
Skin Inflammation in Human Health and Disease, 2021
  • 批准号:
    10222899
  • 项目类别:
  • 资助金额:
    $1.5万
  • 财政年份:
    2021
  • 负责人:
    Rachael Ann Clark
  • 依托单位:
Generation of robust resident memory T cells in barrier tissues through skin vaccination
  • 批准号:
    10408492
  • 项目类别:
  • 资助金额:
    $44.38万
  • 财政年份:
    2021
  • 负责人:
    Rachael Ann Clark
  • 依托单位:
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
  • 批准号:
    10688079
  • 项目类别:
  • 资助金额:
    $39.71万
  • 财政年份:
    2020
  • 负责人:
    Rachael Ann Clark
  • 依托单位:
Optimizing pre-analytic sample handling for high throughput TCR sequencing in cutaneous T cell lymphoma
  • 批准号:
    10053369
  • 项目类别:
  • 资助金额:
    $42.28万
  • 财政年份:
    2020
  • 负责人:
    Rachael Ann Clark
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: